Single Center Evaluation of CryoVein Saphenous Vein Allografts for Coronary Artery Bypass Grafting
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1
- 试验地点
- 1
- 主要终点
- Graft Patency
研究概览
简要总结
The primary objective of this observational study is to evaluate the function (patency) of cryopreserved saphenous vein allografts used as coronary artery bypass grafts (CABG) for patients with occlusive coronary artery disease.
详细描述
This Study is designed as a combination retrospective/prospective single center study in which all patients will be eligible for enrollment based on having a previous implant of CryoVein Saphenous Vein for CABG during the 2008-2010 time frame. A comprehensive chart review of former and previously implanted allograft patients will be performed for the retrospective portion of this Study. An effort will be made to include all patients from this site. Eligible patients will be consented into the Study for a single, prospective, observational imaging evaluation of their bypass conduits.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Any patient implanted with a CryoVein saphenous vein allograft for CABG during 2008 - 2010 time frame.
- •Patients > 18 years of age at implant.
排除标准
- •Patients < 18 years of age.
结局指标
主要结局
Graft Patency
时间窗: 1 to 3 years as defined by the date of their incident operation (CABG surgery).
次要结局
- Morbidity(1 to 3 years defined by the date of their incident operation (CABG surgery))